Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | ANPEP | P15144 | 1/20 | 0.46 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.41 |
| ▸ | ADH1B | P00325 | 1/20 | 0.41 |
| ▸ | ADH1C | P00326 | 1/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
| ▸ | ADH4 | P08319 | 1/20 | 0.41 |
| ▸ | ADH7 | P40394 | 1/20 | 0.41 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.38 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.38 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10495800 | 1.00 | TSHR (0.50) | TSHRALDH1A1ANPEPERAP2EPHX1 | |
| SCHEMBL1532449 | 1.00 | TSHR (0.50) | TSHRALDH1A1ANPEPERAP2EPHX1 | |
| SCHEMBL1668578 | 1.00 | TSHR (0.50) | TSHRALDH1A1ANPEPERAP2EPHX1 | |
| Hydrochloric Acid SCHEMBL28147327 | 0.98 | TSHR (0.48) | TSHRALDH1A1ANPEPERAP2EPHX1 | |
| SCHEMBL6055711 | 0.91 | TSHR (0.46) | TSHRALDH1A1ANPEPERAP2EPHX1 | |
| Octanoic Acid SCHEMBL10495799 | 0.85 | GPR84 (0.53) | TSHRALDH1A1 | |
| SCHEMBL2497316 | 0.83 | FAAH (0.42) | — | |
| SCHEMBL2497320 | 0.83 | FAAH (0.42) | — | |
| SCHEMBL6525778 | 0.81 | ANPEP (0.39) | ANPEPADH1BADH1AADH7 | |
| SCHEMBL6488249 | 0.81 | TSHR (0.48) | TSHRALDH1A1ANPEPERAP2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011005959-A1 | PROCESS FOR THE PREPARATION OF N-PROTECTED-DECYLAMINOETHANAL | PLUS CHEMICALS SA (CH) | 2011-01-13 | — | — | WO | disclosed |
| US-20110009596-A1 | PROCESS FOR THE PREPARATION OF N-PROTECTED-DECYLAMINOETHANAL | PLUS CHEMICALS SA (CH) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009596-A1 | PROCESS FOR THE PREPARATION OF N-PROTECTED-DECYLAMINOETHANAL | PTMA, DNPEP, TET2 | TSHR 3441/4885ALDH1A1 3092/4885ANPEP 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.